New Zealand Approves MDMA Prescription for Severe PTSD Treatment

New Zealand has granted two psychiatrists permission to prescribe pharmaceutical-grade MDMA to patients suffering from severe post-traumatic stress disorder. The approval was announced on Friday, marking a significant regulatory step for the controlled substance in the country. MDMA, commonly known as a party drug, is being explored medically for its potential to aid trauma recovery. The move reflects a growing global interest in psychedelic-assisted therapies for mental health conditions that are difficult to treat through conventional means.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in